Literature DB >> 23994597

DAMGO in the central amygdala alleviates the affective dimension of pain in a rat model of inflammatory hyperalgesia.

R-X Zhang1, M Zhang, A Li, L Pan, B M Berman, K Ren, L Lao.   

Abstract

Pain has sensory-discriminative and emotional-affective dimensions. Recent studies show that the affective component can be assessed with a conditioned place avoidance (CPA) test. We hypothesized that systemic morphine before a post-conditioning test would more potently attenuate the affective aspect compared to the sensory component and that [d-Ala2-N-Me-Phe4, Gly-ol5]-enkephalin (DAMGO), a μ-selective opioid receptor agonist, injected into the central nucleus of the amygdala (CeA) would reduce established CPA. A rat model of inflammatory pain, produced by a complete Freund adjuvant (CFA) injection into the hind paw, was combined with a CPA test. Three experiments were performed on adult male Sprague-Dawley rats. Systemic morphine (0.5 or 1.0mg/kg) in Experiment 1, intrathecal (i.t.) morphine (2.5 μg/rat) in Experiment 2, and intra-CeA DAMGO (7.7-15.4 ng/0.4 μl) in Experiment 3 were given to CFA-injected rats (n=6-8/group) prior to a post-conditioning test. Saline-injected rats were used as control. Time spent in a pain-paired compartment was recorded twice, before conditioning and after a post-conditioning test. Paw withdrawal latency (PWL) to a noxious thermal stimulus was measured before experiment at day-1 and after the post-conditioning test; hyperalgesia was defined as a decrease in PWL. The data showed that CFA-injected rats had significantly negative CPA compared to those of saline-injected rats (P<0.05). Low-dosage systemic morphine significantly (P<0.05) reduced CFA-induced CPA but had no effect on PWL. I.t. morphine did not inhibit the display of CPA but significantly increased PWL, suppressing hyperalgesia (P<0.05). Intra-CeA DAMGO significantly inhibited the display of CPA compared to saline (P<0.05) but had no effect on PWL. The data demonstrate that morphine attenuates the affective component more powerfully than it does the sensory and suggests that the sensory and the emotional-affective dimensions are underpinned by different mechanisms.
Copyright © 2013 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BLA; CFA; CPA; CeA; DAMGO; IACUC; Institutional Animal Care and Use Committee; N-methyl-d-aspartate; NMDA; PWL; [d-Ala2-N-Me-Phe4, Gly-ol5]-enkephalin; amygdala; basolateral amygdaloid nucleus; central nucleus of the amygdala; complete Freund adjuvant; conditioned place avoidance; hyperalgesia; opioid; pain; paw withdrawal latency; spinal cord

Mesh:

Substances:

Year:  2013        PMID: 23994597      PMCID: PMC3864641          DOI: 10.1016/j.neuroscience.2013.08.030

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  29 in total

1.  Functional and anatomical localization of mu opioid receptors in the striatum, amygdala, and extended amygdala of the nonhuman primate.

Authors:  J B Daunais; S R Letchworth; L J Sim-Selley; H R Smith; S R Childers; L J Porrino
Journal:  J Comp Neurol       Date:  2001-05-14       Impact factor: 3.215

2.  The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex.

Authors:  J P Johansen; H L Fields; B H Manning
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

3.  Inhibition of glutamatergic transmission by morphine in the basolateral amygdaloid nucleus reduces pain-induced aversion.

Authors:  Satoshi Deyama; Junki Yamamoto; Taiichi Machida; Sachi Tanimoto; Takayuki Nakagawa; Shuji Kaneko; Masamichi Satoh; Masabumi Minami
Journal:  Neurosci Res       Date:  2007-07-01       Impact factor: 3.304

4.  A lateralized deficit in morphine antinociception after unilateral inactivation of the central amygdala.

Authors:  B H Manning
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

5.  Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain.

Authors:  Ron C Kupers; Herman Konings; Hugo Adriaensen; Jan M Gybels
Journal:  Pain       Date:  1991-10       Impact factor: 6.961

Review 6.  Opioids in the brain: supraspinal mechanisms in pain control.

Authors:  T S Jensen
Journal:  Acta Anaesthesiol Scand       Date:  1997-01       Impact factor: 2.105

7.  A parametric study of electroacupuncture on persistent hyperalgesia and Fos protein expression in rats.

Authors:  Lixing Lao; Rui-Xin Zhang; Grant Zhang; Xiaoya Wang; Brian M Berman; Ke Ren
Journal:  Brain Res       Date:  2004-09-10       Impact factor: 3.252

8.  Intravenous morphine depresses the transmission of noxious messages to the nucleus centralis of the amygdala.

Authors:  G F Huang; J M Besson; J F Bernard
Journal:  Eur J Pharmacol       Date:  1993-06-04       Impact factor: 4.432

9.  Involvement of dorsal hippocampal nicotinic receptors in the effect of morphine on memory retrieval in passive avoidance task.

Authors:  Lotfollah Khajehpour; Ameneh Rezayof; Mohammad-Reza Zarrindast
Journal:  Eur J Pharmacol       Date:  2008-02-19       Impact factor: 4.432

10.  Serotonin Receptor 2A/C Is Involved in Electroacupuncture Inhibition of Pain in an Osteoarthritis Rat Model.

Authors:  Aihui Li; Yu Zhang; Lixing Lao; Jiajia Xin; Ke Ren; Brian M Berman; Rui-Xin Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-09       Impact factor: 2.629

View more
  16 in total

1.  Activation of enkephalinergic (Enk) interneurons in the central amygdala (CeA) buffers the behavioral effects of persistent pain.

Authors:  Tanvi Paretkar; Eugene Dimitrov
Journal:  Neurobiol Dis       Date:  2018-12-17       Impact factor: 5.996

Review 2.  Amygdala pain mechanisms.

Authors:  Volker Neugebauer
Journal:  Handb Exp Pharmacol       Date:  2015

3.  Effects of paclitaxel on mechanical sensitivity and morphine reward in male and female C57Bl6 mice.

Authors:  Harshini Neelakantan; Sara Jane Ward; Ellen Ann Walker
Journal:  Exp Clin Psychopharmacol       Date:  2016-12       Impact factor: 3.157

4.  Opioids differentially modulate two synapses important for pain processing in the amygdala.

Authors:  Sarah A Kissiwaa; Sahil D Patel; Bryony L Winters; Elena E Bagley
Journal:  Br J Pharmacol       Date:  2020-01-08       Impact factor: 8.739

Review 5.  Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain.

Authors:  Kaitlin C Reeves; Nikhil Shah; Braulio Muñoz; Brady K Atwood
Journal:  Front Mol Neurosci       Date:  2022-06-15       Impact factor: 6.261

6.  Expression and pharmacological modulation of visceral pain-induced conditioned place aversion in mice.

Authors:  Deniz Bagdas; Pretal P Muldoon; Shakir AlSharari; F Ivy Carroll; S Stevens Negus; M Imad Damaj
Journal:  Neuropharmacology       Date:  2015-11-27       Impact factor: 5.250

7.  Effect of nicotine and alpha-7 nicotinic modulators on visceral pain-induced conditioned place aversion in mice.

Authors:  D Bagdas; J A Meade; Y Alkhlaif; P P Muldoon; F I Carroll; M I Damaj
Journal:  Eur J Pain       Date:  2018-04-10       Impact factor: 3.931

Review 8.  Interactive Mechanisms of Supraspinal Sites of Opioid Analgesic Action: A Festschrift to Dr. Gavril W. Pasternak.

Authors:  Grace C Rossi; Richard J Bodnar
Journal:  Cell Mol Neurobiol       Date:  2020-09-24       Impact factor: 5.046

9.  Endogenous µ-opioid receptor activity in the lateral and capsular subdivisions of the right central nucleus of the amygdala prevents chronic postoperative pain.

Authors:  Andrew H Cooper; Naomi S Hedden; Gregory Corder; Sydney R Lamerand; Renee R Donahue; Julio C Morales-Medina; Lindsay Selan; Pranav Prasoon; Bradley K Taylor
Journal:  J Neurosci Res       Date:  2021-05-06       Impact factor: 4.164

10.  Selective modulation of tonic aversive qualities of neuropathic pain by morphine in the central nucleus of the amygdala requires endogenous opioid signaling in the anterior cingulate cortex.

Authors:  Edita Navratilova; Kelsey Nation; Bethany Remeniuk; Volker Neugebauer; Kirsty Bannister; Anthony H Dickenson; Frank Porreca
Journal:  Pain       Date:  2020-03       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.